Active	Status	Sponsor type	Region	Phase	Filter
3 Active 1 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   - « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
QBS72S / Quadriga Biosci
NCT05305365: Study Assessing QBS72S For Treating Brain Metastases	Recruiting	2	40	US	QBS72S, QBS10072S	Melanie Hayden Gephart, Quadriga Biosciences, Inc.	Brain Metastases, Breast Cancer, Lung Cancer, Leptomeningeal Disease, LMD	08/25	08/26
NCT06810804: A Phase IIa Study to Evaluate NBQ72S	Not yet recruiting	2	10	NA	NBQ72S, QBS10072S	Nantong Bencao Quadriga Medical Technology Co. Ltd.	Breast Cancer	08/26	02/27
INSIGhT, NCT02977780: INdividualized Screening Trial of Innovative Glioblastoma Therapy	Recruiting	2	460	US	Temozolomide, Temodar, Neratinib, QBS10072S	Patrick Wen, MD, Eli Lilly and Company, Celgene, Puma Biotechnology, Inc., Accelerate Brain Cancer Cure, Quadriga Biosciences, Inc.	Glioblastoma	02/27	04/27

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
QBS72S / Quadriga Biosci
NCT05305365: Study Assessing QBS72S For Treating Brain Metastases	Recruiting	2	40	US	QBS72S, QBS10072S	Melanie Hayden Gephart, Quadriga Biosciences, Inc.	Brain Metastases, Breast Cancer, Lung Cancer, Leptomeningeal Disease, LMD	08/25	08/26
NCT06810804: A Phase IIa Study to Evaluate NBQ72S	Not yet recruiting	2	10	NA	NBQ72S, QBS10072S	Nantong Bencao Quadriga Medical Technology Co. Ltd.	Breast Cancer	08/26	02/27
INSIGhT, NCT02977780: INdividualized Screening Trial of Innovative Glioblastoma Therapy	Recruiting	2	460	US	Temozolomide, Temodar, Neratinib, QBS10072S	Patrick Wen, MD, Eli Lilly and Company, Celgene, Puma Biotechnology, Inc., Accelerate Brain Cancer Cure, Quadriga Biosciences, Inc.	Glioblastoma	02/27	04/27